Recent Quotes
My Watchlist
Indicators
MJS Wisconsin Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

66.38 USD +0.43 (+0.65%)
Official Closing Price Updated: 7:59 PM EDT, Apr 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Gilead Sciences

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ATRC ALKS AVIR
From Benzinga
The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ORGO PRLD NK
From Benzinga
2 Ultra-High-Growth Healthcare Stocks That Are Just Getting Started
Both stocks are in the early stage of a long-term growth trajectory. 
Tags TAK BCRX BMY
From Motley Fool
Where Will Gilead Sciences Be in 1 Year?
This blue-chip biotech is a risky bet going forward, but it is also dirt cheap. 
Tags GILD MRNA Market News
From Motley Fool
Noteworthy Tuesday Option Activity: BJRI, AXSM, GILD
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BJ's Restaurants Inc (BJRI), where a total of 1,894 contracts have traded so far,... 
Tags Stocks
From Market News Video
Gilead Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Daniel O’Day, Gilead’s Chairman and Chief Executive Officer, will provide an overview of the company at the 39th Annual J.P. Morgan Healthcare... 
From Business Wire News Releases
Should Investors Consider This Biotech Takeover Target?
Getting in on the extensive merger and acquisition game of large pharmaceutical companies is the ultimate endgame for Exelixis, a biotech that already boasts an established cancer-focused product... 
Tags IMMU MNTA EXEL
From Motley Fool
2 Best Biotech Stocks to Buy in December
Paying an excellent price for high-flying biotech stocks and holding has been a profitable investing strategy. 
Tags REGN GILD IBB
From Motley Fool
Down 9% in 2020, Is Biogen Now a Buy?
The company isn't standing still while its Alzheimer's drug is up in the air. 
Tags DNLI GILD Market News
From Motley Fool
20 best mid-cap stocks for 2021, according to analysts
Companies including Ligand Pharmaceuticals and LendingTree are expected by analysts to post double-digit revenue growth next year. 
Tags LGND TMHC TPH
From MarketWatch
Glioblastoma Multiforme (GBM) Treatments Advancing as FDA Steps Up Measures Due to Rising Incidences
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Glioblastoma Multiforme (GBM) Treatments Advancing as FDA Steps Up Measures Due to Rising Incidences
Financialnewsmedia.com News Commentary 
From PR Newswire
The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MGTX HUM GSK
From Benzinga
Could Trillium Fall Below $10 in 2021?
A decline in the stock price plus positive clinical data equals opportunity. 
Tags Market News PFE TRIL
From Motley Fool
GILD: A Big Biotech on the Verge of an Upgrade
Gilead has a short but solid dividend-paying track record and a nice, low payout ratio. The only knock on the stock from a dividend safety standpoint has been falling cash flow. That puts the stock at... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Megatrends To Invest In Now: 3 Best ETF Picks
BlackRock has identified five big trends that are here to stay for the long haul. Investors can get exposure to these drivers via 17 iShares ETFs. 
From Investor's Business Daily
Galapagos Stock Crumbles After Its Gilead Arthritis Deal Falls Apart
Gilead Sciences cut its losses on a rheumatoid arthritis treatment in partnership with Galapagos, sending GLPG stock tumbling on Wednesday. Gilead stock also fell less than 1%. 
From Investor's Business Daily
IBB, GILD, MRNA, VRTX: ETF Outflow Alert
Symbols mentioned in this story: IBB, GILD, MRNA, VRTX Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
How To Trade Stocks: Do You Know The Seven Most Important Words On Wall Street?
Want to learn how to trade stocks successfully? First examine fundamentals. And keep these seven key words on Wall Street in mind. 
From Investor's Business Daily
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VVOS FREQ MNKD
From Benzinga
Kite’s Tecartus™ (KTE-X19) Granted Conditional Marketing Authorization for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma in Europe
Kite, a Gilead Company (Nasdaq: GILD), today announced that the European Commission has granted conditional marketing authorization for Tecartus™ (autologous, anti-CD19-transduced CD3+ cells; formerly... 
From Business Wire News Releases
Gilead and Galapagos announce New Commercialization and Development Agreement for Jyseleca® (filgotinib)
From GlobeNewswire News Releases
Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca® (Filgotinib)
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) today announced that the companies have agreed to amend their existing arrangement for the commercialization and... 
From Business Wire News Releases
Zoetis Now #92 Largest Company, Surpassing Gilead Sciences
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Zoetis Inc (ZTS) has taken over the #92 spot from Gilead Sciences Inc (GILD), according to The... 
Tags Stocks
From Market News Video
Private Equity EQT Offers To Acquire Swedish Pharma Recipharm For $2.1B
Stockholm headquartered private equity groupEQT ABwill buy Swedish pharma companyRecipharm ABfor $2.1 billion, ... 
Tags News General Bloomberg
From Benzinga
Weighing The Week Ahead: What Can Investors Do About Gridlock?
U.S. leadership has been unable to reach a stimulus package that can garner enough support. Investors are curious: What does Washington gridlock mean for investment portfolios? 
Tags Stocks / Equities
From Blogs - TalkMarkets
The Most Popular Coronavirus Stock May Lose Half Its Value by 2023
This as-of-now unstoppable COVID-19 stock might be one of the worst investments going forward. 
Tags MRNA PFE GILD
From Motley Fool
74 Firms going Ex-Dividend next week, including Merck, Gilead and Public Storage
There are several well known large cap stocks going ex-dividend next week 
Tags Stocks / Equities
From Blogs - TalkMarkets
3 Stocks That Are Giving Their Investors Coal in Their Stockings
Naughty or nice, shareholders aren't getting anything on their wish lists from these stocks this year. 
Tags BIIB SAGE VRTX
From Motley Fool
Notable Friday Option Activity: EXPE, ULTA, GILD
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Expedia Group Inc (EXPE), where a total volume of 17,524 contracts has been traded thus... 
Tags Stocks
From Market News Video
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.